文献速递精神分裂症与精神病性障碍心境障碍

精神分裂症或双相障碍患者身体活动干预的成本效果分析:系统综述

Cost-effectiveness analysis of physical activity interventions for people with schizophrenia or bipolar disorder: systematic review.
PubMed 文献 · Br J Psychiatry · 2023-08-01

混合结果显示部分研究认为成本有效、部分认为非成本有效,证据提示男性、合并2型糖尿病及精神科住院≥1年的患者亚组可能更受益。

要点

  • 纳入研究均评估多组分生活方式干预中的身体活动成分,成本效果结论不一致。
  • 有限证据提示男性、合并2型糖尿病及住院≥1年患者亚组可能更受益。
  • 亟需未来研究识别不同患者亚组的成本有效身体活动干预模式。

核心结论

  • 当前经济学证据提示并非所有包含身体活动干预的多组分生活方式干预模式对精神分裂症或双相障碍患者均成本有效。
  • 并非所有精神分裂症或双相障碍患者均同等受益于该干预。
  • 亟需未来研究识别不同患者亚组的成本有效身体活动干预模式。

研究设计与样本

  • 系统综述检索MEDLINE、Embase、PsycInfo和Scopus四个数据库,检索日期为2022年7月5日。
  • 基于检索到的研究进行前向和后向引文检索。
  • 两名评价者独立筛选纳入研究,使用Drummond清单评估研究质量,采用叙述性综合呈现结果。

主要发现

  • 所有纳入研究均在多组分生活方式干预中评估身体活动干预。
  • 三项研究报告多组分生活方式干预成本有效。
  • 四项研究报告多组分生活方式干预非成本有效。
  • 两项研究未得出多组分生活方式干预是否成本有效的结论。
  • 非常有限证据提示男性、合并2型糖尿病及精神科住院≥1年的患者亚组可能更可能受益于含身体活动成分的多组分生活方式干预。

关键数值与推荐

  • 纳入研究质量范围为中等至高等。
  • 多组分生活方式干预成本效果结论:3项研究成本有效,4项研究非成本有效,2项研究未得出结论。

临床怎么用

  • 临床指南推荐为精神分裂症或双相障碍患者提供身体活动干预以管理体重。
  • 当前证据提示应关注患者亚组差异,男性、合并2型糖尿病及精神科住院≥1年者可能更受益。
  • 实施含身体活动成分的多组分生活方式干预时需考虑成本效果的不确定性。

局限性

  • 身体活动干预的成本效果此前未知,本综述纳入研究均评估多组分生活方式干预中的身体活动成分。
  • 仅非常有限证据提示特定患者亚组可能更受益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical guidelines recommend providing physical activity interventions (PAIs) to people with schizophrenia or bipolar disorder for weight management. However, the cost-effectiveness of PAIs is unknown. AIMS: To evaluate the availability and methodological quality of economic evaluations of PAIs for people with schizophrenia or bipolar disorder. METHOD: Four databases (MEDLINE, Embase, PsycInfo and Scopus) were searched on 5 July 2022. Based on the retrieved studies, forward and backward citation searches were conducted. Two reviewers independently selected studies for inclusion. Study quality was assessed using the Drummond checklist. Review results were presented using narrative synthesis. RESULTS: Fourteen articles reporting nine studies were included. All included studies assessed PAIs within a multicomponent lifestyle intervention. Mixed findings were reported on the cost-effectiveness of multicomponent lifestyle intervention: three studies reported it as cost-effective; four studies reported it as not cost-effective; and two studies did not conclude whether it was cost-effective or not. Very limited evidence suggests that certain patient subgroups might be more likely to benefit from multicomponent lifestyle interventions with a PAI component: men; individuals with comorbid type 2 diabetes; and individuals who have been psychiatric hospital in-patients for ≥1 year. The quality of included studies ranged from moderate to high. CONCLUSIONS: The current economic evidence suggests that not all modalities of multicomponent lifestyle intervention including a PAI component are cost-effective for people with schizophrenia or bipolar disorder; and not all people with schizophrenia or bipolar disorder would benefit equally from the intervention. Future research is urgently needed to identify the cost-effective modality of PAI for different patient subgroups.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jin H, Kolawole O, Wang Z, et al. Cost-effectiveness analysis of physical activity interventions for people with schizophrenia or bipolar disorder: systematic review. Br J Psychiatry. 2023. PMID: 37526007. doi:10.1192/bjp.2023.52

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。